Invest Victoria is changing operations to remain open throughout the COVID-19 pandemic
If you are considering investing in Melbourne, Invest Victoria can help you scope the market opportunity and assist you with your business case development through the planning, setting up or ongoing growth stages of your business life cycle.
A leading Victorian company is exploring the potential for its antiviral compound to prevent and manage coronavirus (COVID-19).
Australia’s premier biomedical precinct in Melbourne, Parkville, has received a further boost with the opening of the new $75 million National Drug Discovery Research Centre at the Walter and Eliza Hall Institute of Medical Research.
A blueprint to attract more international investment to Victoria to grow the State’s economy and create jobs.
We offer investors a stable and competitive business environment with longstanding ties to Asia, a skilled multicultural workforce, world-class institutions and infrastructure and unbeatable lifestyle. These attributes generate exciting, diverse and unique opportunities for investors.
As the Tech City of Australia, Melbourne is the Asia Pacific base for leading US tech companies like Square, Zendesk, Culture Amp and Airwallex. Most of Australia's tech talent graduate in Melbourne, and the city is one of the world's most liveable in the world.
One of Brazil’s leading renewable energy advisory and management companies will establish its Australian and New Zealand HQ in Melbourne, further cementing Victoria’s strong credentials as a leader in renewable energy.
In a boost for Victoria’s thriving medical research industry, the Peter Doherty Institute for Infection and Immunity has been awarded AU$3.2 million by the Jack Ma Foundation to expedite the creation of a vaccine against the coronavirus.